Published on
10:38 GMT
The Pros and Cons of Complement Inhibition
Since receiving FDA approval for use in patients with geographic atrophy, both pegcetacoplan (Syfovre, Apellis) and avacincaptad pegol (Izervay, Astellas Pharma) have been the talk of the retina community. Many retina specialists feel excitement over the …
Source:
Review of Ophthalmology
-
Neutral
)
)
